| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.
|
J Am Acad Dermatol
|
2013
|
2.25
|
|
2
|
Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons.
|
Arch Dermatol
|
2010
|
2.24
|
|
3
|
Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
|
JAMA Dermatol
|
2013
|
1.88
|
|
4
|
Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
|
J Clin Oncol
|
2013
|
1.83
|
|
5
|
Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study.
|
JAMA Dermatol
|
2013
|
1.55
|
|
6
|
A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus.
|
JAMA Dermatol
|
2014
|
1.37
|
|
7
|
Management of high-risk cutaneous squamous cell carcinoma.
|
J Clin Aesthet Dermatol
|
2010
|
1.30
|
|
8
|
Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study.
|
Dermatol Surg
|
2009
|
1.14
|
|
9
|
Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin.
|
J Invest Dermatol
|
2009
|
1.13
|
|
10
|
Comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.
|
J Surg Oncol
|
2014
|
1.07
|
|
11
|
Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses.
|
J Invest Dermatol
|
2013
|
1.06
|
|
12
|
Update on the management of high-risk squamous cell carcinoma.
|
Semin Cutan Med Surg
|
2011
|
1.03
|
|
13
|
Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas.
|
J Invest Dermatol
|
2012
|
0.92
|
|
14
|
Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell and squamous cell carcinoma in patients undergoing Mohs micrographic surgery.
|
Dermatol Surg
|
2008
|
0.83
|
|
15
|
Metastatic eccrine porocarcinoma after Mohs micrographic surgery: a case report.
|
J Clin Oncol
|
2012
|
0.79
|
|
16
|
A comparison of high- and low-cost infection-control practices in dermatologic surgery.
|
Arch Dermatol
|
2012
|
0.78
|
|
17
|
Heightened infection-control practices are associated with significantly lower infection rates in office-based Mohs surgery.
|
Dermatol Surg
|
2010
|
0.78
|
|
18
|
Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients.
|
Dermatol Surg
|
2016
|
0.78
|
|
19
|
Association between type of reconstruction after Mohs micrographic surgery and surgeon-, patient-, and tumor-specific features: a cross-sectional study.
|
Dermatol Surg
|
2012
|
0.77
|
|
20
|
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
|
J Natl Compr Canc Netw
|
2016
|
0.76
|
|
21
|
Impact of National Comprehensive Cancer Network Guidelines on Case Selection and Outcomes for Sentinel Lymph Node Biopsy in Thin Melanoma.
|
Dermatol Surg
|
2017
|
0.75
|
|
22
|
Effect of physical activity on nonmelanoma skin cancer risk in kidney, liver, and pancreatic transplant patients.
|
Dermatol Surg
|
2010
|
0.75
|
|
23
|
Aneurysmal dermatofibroma successfully treated with Mohs micrographic surgery.
|
Dermatol Surg
|
2015
|
0.75
|
|
24
|
The Z-advancement flap for reconstruction of lateral nasal tip and medial alar defects.
|
Dermatol Surg
|
2013
|
0.75
|
|
25
|
Treatment Patterns, Outcomes, and Patient Satisfaction of Primary Epidermally Limited Nonmelanoma Skin Cancer.
|
Dermatol Surg
|
2017
|
0.75
|